Apogee Therapeutics, Inc. · NASDAQ:APGE
Wellington Management Group LLP reported a 10.60% stake in Apogee Therapeutics, Inc. (Schedule 13G/A)
Event Jul 31, 2025 · Filed Aug 5, 2025
Wellington Management Group LLP reported a 10.60% stake in Apogee Therapeutics, Inc., 4,885,146 shares, as a passive investor on Jul 31, 2025. Filed Aug 5, 2025 (Schedule 13G/A).
- Stake
- 10.60%
- Shares
- 4,885,146
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 10.60% | 4,885,146 |
| Wellington Group Holdings LLP | 10.60% | 4,885,146 |
| Wellington Investment Advisors Holdings LLP | 10.60% | 4,885,146 |
| Wellington Management Company LLP | 10.30% | 4,885,146 |
Source
Related
- Apogee Therapeutics, Inc.
- Wellington Management Group LLP
- Apogee Therapeutics, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Jul 8, 2026
- Schedule 13G/A · Wellington Management Group LLP · Feb 10, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 5, 2025
- Schedule 13G/A · Wellington Management Group LLP · May 12, 2025
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026